News
20hon MSN
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
15h
Zacks Investment Research on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...
10h
Barchart on MSNA $1.3 Billion Reason to Buy Eli Lilly Stock NowEli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results